Related Experiment Video
Updated: Jun 24, 2025

Measuring the Carotid to Femoral Pulse Wave Velocity Cf-PWV to Evaluate Arterial Stiffness
Published on: May 3, 2018
Subclinical vascular, hemodynamic and arterial stiffness changes in adults with cystic fibrosis: cross-sectional
Bruno Porto Pessoa1,2,3, Marcelo Velloso3,4, Érika Pereira Inácio2
1Post-Graduate Program in Health Sciences of Medical Sciences Faculty of Minas Gerais, Alameda Ezequiel Dias, 275-Centro, Belo Horizonte, MG, 30130-110, Brazil.
Insights
Adults with cystic fibrosis (CF) show lower blood pressure and cardiac output but increased arterial stiffness, indicating a higher risk for cardiovascular disease. Early cardiovascular assessment is recommended for CF patients.
Area of Science:
- Cardiology
- Pulmonology
- Vascular Physiology
Background:
- Improved life expectancy in cystic fibrosis (CF) patients leads to emerging cardiovascular complications.
- Understanding cardiovascular health in aging CF populations is crucial for comprehensive care.
Purpose of the Study:
- To compare vascular and hemodynamic parameters, including arterial stiffness, in adult CF patients versus healthy controls.
- To identify factors associated with arterial stiffness in individuals with CF.
Main Methods:
- A cross-sectional observational study involving 36 CF patients and 35 controls.
- Non-invasive cardiovascular evaluation using the Mobil-O-Graph device.
- Analysis of vascular, hemodynamic parameters, and arterial stiffness indices like augmentation index (AIx@75).
Main Results:
- CF patients exhibited significantly lower mean arterial pressure, cardiac output, and stroke volume compared to controls.
- Heart rate was higher in CF patients, while augmentation index (AIx@75), an indicator of arterial stiffness, was significantly elevated.
- Multivariate analysis revealed central systolic blood pressure and reflection coefficient were directly related to AIx@75, while age and stroke volume were negatively related.
Conclusions:
- Individuals with CF present with altered cardiovascular parameters, including reduced arterial blood pressure and cardiac function, alongside increased arterial stiffness.
- Elevated AIx@75 in CF patients suggests increased arterial stiffness and potential left ventricular overload.
- Subclinical cardiovascular changes necessitate earlier and regular cardiovascular assessments in CF patients to mitigate risks.
Abstract:
Cardiovascular diseases can be an emerging complication in cystic fibrosis (CF), as the median life expectancy has improved considerably. The objective of this study was to compare vascular, hemodynamic parameters and arterial stiffness in adult CF patients with healthy participants pared by sex and age, and to assess the factors associated with arterial stiffness in the CF group. This is a cross-sectional observational study. The evaluation of cardiovascular parameters was performed non-invasively using Mobil-O-Graph. 36 individuals with CF and 35 controls were evaluated. The mean arterial pressure (96.71 ± 10.98 versus 88.61 ± 7.40 mmHg, p = 0.0005), cardiac output (4.86 ± 0.57 versus 4.48 ± 0.44 L/min, p = 0.002) and systolic volume (64.30 ± 11.91 versus 49.02 ± 9.31 ml, p < 0.0001) were significantly lower in the CF group. The heart rate was higher in the CF when compared to the control (77.18 ± 10.47 versus 93.56 ± 14.57 bpm, p < 0.0001). The augmentation index (AIx@75) was higher in the CF than control (29.94 ± 9.37 versus 16.52 ± 7.179%, p < 0.0001). In the multivariate model controlled by body mass index and Forced Expiratory Volume in the first second, central systolic blood pressure and reflection coefficient directly related to AIx@75. Negatively related to AIx@75 were age and systolic volume. The adjusted determination coefficient was 87.40%. Individuals with CF presented lower arterial blood pressures and changes in cardiac function with lower stroke volume and cardiac output. The AIx@75, an indirect index of arterial stiffness and direct index of left ventricular overload, is increased in this population. The subclinical findings suggest the need for earlier cardiovascular assessment in this population due to increased risks of cardiovascular disease.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Cystic Fibrosis: Management
Sinus disease and chronic...

